Preclinical study of the antitumor effect of sphingosine-1-phosphate receptor 1 antibody (S1PR1-antibody) against human breast cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical study of the antitumor effect of sphingosine-1-phosphate receptor 1 antibody (S1PR1-antibody) against human breast cancer cells
Authors
Keywords
S1PR<sub>1</sub>-antibody, Sphingosine-1-phosphate, Carboplatin, HER2 subtype breast cancer, Triple-negative subtype breast cancer
Journal
INVESTIGATIONAL NEW DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-06-02
DOI
10.1007/s10637-018-0618-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood–brain barrier integrity and exerts therapeutic effect in an animal model of Huntington’s disease
- (2018) Alba Di Pardo et al. HUMAN MOLECULAR GENETICS
- Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss
- (2018) Sarah Weske et al. NATURE MEDICINE
- Sphingosine 1-Phosphate Receptor 1 Is Required for MMP-2 Function in Bone Marrow Mesenchymal Stromal Cells: Implications for Cytoskeleton Assembly and Proliferation
- (2018) Chiara Sassoli et al. Stem Cells International
- Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer
- (2017) Eriko Katsuta et al. JOURNAL OF SURGICAL RESEARCH
- Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation
- (2017) Catherine Olesch et al. MEDIATORS OF INFLAMMATION
- Overexpression of sphingosine kinase 1 is predictive of poor prognosis in human breast cancer
- (2017) Ya-Jing Zhu et al. Oncology Letters
- S1PR1 mediates anti-apoptotic/pro-proliferative processes in human acute myeloid leukemia cells
- (2016) Xiao-Qian Xu et al. Molecular Medicine Reports
- miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation
- (2016) NAN CHENG et al. Experimental and Therapeutic Medicine
- Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target
- (2015) Heounjeong Go et al. EUROPEAN JOURNAL OF CANCER
- Sphingosine kinase 1 as an anticancer therapeutic target
- (2015) Ying Gao et al. Drug Design Development and Therapy
- Sphingosine kinase 2 prevents the nuclear translocation of sphingosine 1-phosphate receptor-2 and tyrosine 416 phosphorylated c-Src and increases estrogen receptor negative MDA-MB-231 breast cancer cell growth: The role of sphingosine 1-phosphate receptor-4
- (2014) Jan Ohotski et al. CELLULAR SIGNALLING
- Sphingolipid metabolites in inflammatory disease
- (2014) Michael Maceyka et al. NATURE
- Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation
- (2014) Naoya Hirata et al. Nature Communications
- Synergistic Effect between Sphingosine-1-Phosphate and Chemotherapy Drugs against Human Brain-metastasized Breast Cancer MDA-MB-361 cells
- (2013) Ahlam Sultan et al. Journal of Cancer
- Blocking S1P interaction with S1P1 receptor by a novel competitive S1P1-selective antagonist inhibits angiogenesis
- (2012) Yasuyuki Fujii et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer
- (2012) Isabelle J Létourneau et al. BMC CANCER
- Targeting sphingosine kinase-1 to inhibit melanoma
- (2012) SubbaRao V. Madhunapantula et al. Pigment Cell & Melanoma Research
- Sphingosine kinase 1 overexpression is regulated by signaling through PI3K, AKT2, and mTOR in imatinib-resistant chronic myeloid leukemia cells
- (2011) Gabriella Marfe et al. EXPERIMENTAL HEMATOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Platinum resistance in breast and ovarian cancer cell lines
- (2011) Niels Eckstein JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Sphingosine Kinase 1 Induces Tolerance to Human Epidermal Growth Factor Receptor 2 and Prevents Formation of a Migratory Phenotype in Response to Sphingosine 1-Phosphate in Estrogen Receptor-Positive Breast Cancer Cells
- (2010) J. S. Long et al. MOLECULAR AND CELLULAR BIOLOGY
- Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients
- (2009) W. Li et al. CLINICAL CANCER RESEARCH
- Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancer
- (2009) Binbing Ling et al. INVESTIGATIONAL NEW DRUGS
- "Inside-Out" Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
- (2008) K. Takabe et al. PHARMACOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now